KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial.Lancet HIVPMID 37494942无 PMCID2023-Oct0.98未发现恶性肿瘤人群证据。待处理
The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis.Muscle NervePMID 37525592无 PMCID2023-Oct0.98未发现恶性肿瘤人群证据。待处理
En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial.Eur Urol OncolPMID 37543464无 PMCID2023-Oct0.95The trial is an oncology, human, randomized, Phase III study with a time-to-event endpoint (recurrence-free survival reported via Cox HR). However, the intervention is purely surgical (en bloc vs conventional resection) with no drug component. Per adjudication rules, a drug-containing intervention is required for eligibility. Therefore, the record is excluded.待处理
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trial.EpilepsiaPMID 37543865无 PMCID2023-Oct0.98未发现恶性肿瘤人群证据。待处理
Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS).J UrolPMID 37548555PMC127216582023-Oct0.85The record describes a randomized Phase III trial with a time-to-event primary endpoint (disease-free survival). However, the intervention (UGN-102) is a drug-containing gel for local chemoablation, and the study is framed as a comparison of a chemoablation technique versus a surgical procedure (TURBT). The adjudication rules require a 'drug-containing intervention,' but the context and primary analysis emphasize the procedural/ablation aspect, making the drug component not the clear, primary therapeutic modality under test. Therefore, it does not meet the strict criterion for a drug intervention as defined for this cohort.待处理
Efficacy and safety of lemborexant in subjects previously treated with placebo for 6 months in a randomized phase 3 study.Sleep MedPMID 37574610无 PMCID2023-Oct0.98未发现恶性肿瘤人群证据。待处理
Randomized controlled trial of the behavioral intervention for physical activity in multiple sclerosis project: Social cognitive theory variables as mediators.Mult Scler Relat DisordPMID 37586313无 PMCID2023-Oct0.98未发现恶性肿瘤人群证据。待处理
Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET).Adv TherPMID 37603205PMC104999482023-Oct0.98未发现恶性肿瘤人群证据。待处理
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial.LeukemiaPMID 37604981PMC105391672023-Oct0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
A randomized phase III study of docetaxel alone versus docetaxel plus S-1 in patients with previously treated non-small cell lung cancer: JMTO LC09-01.Thorac CancerPMID 37609677PMC105699022023-Oct0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.Lancet Diabetes EndocrinolPMID 37619579PMC105227782023-Oct0.90The record is a phase 3 randomized trial of adjuvant mitotane versus surveillance in adrenocortical carcinoma with a primary time-to-event endpoint (RFS) and secondary OS, reporting hazard ratios. It meets all eligibility criteria for an original formal result.待处理
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer.Gynecol OncolPMID 37625235PMC109864252023-Oct0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation.Antivir TherPMID 37657421无 PMCID2023-Oct0.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trial.Eur J CancerPMID 37660438无 PMCID2023-Oct0.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Psychometric evaluation of the Worst Pruritus Numerical Rating Scale (NRS), Atopic Dermatitis Symptom Scale (ADerm-SS), and Atopic Dermatitis Impact Scale (ADerm-IS).Curr Med Res OpinPMID 37691437无 PMCID2023-Oct0.98未发现恶性肿瘤人群证据。待处理
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.Lancet OncolPMID 37708912无 PMCID2023-Oct0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.Nat MedPMID 37709999PMC105790912023-Oct0.98未发现恶性肿瘤人群证据。待处理
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial.Lancet OncolPMID 37714168无 PMCID2023-Oct0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.Lancet NeurolPMID 37739572无 PMCID2023-Oct0.98未发现恶性肿瘤人群证据。待处理
Efficacy of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine for the prevention of mucositis induced by platinum-based chemoradiation in head and neck cancer: A phase II study.Clin Nutr ESPENPMID 37739730无 PMCID2023-Oct0.80The study is a Phase II randomized trial in head and neck cancer, but it fails several key inclusion criteria: it is not a Phase III/IIIb trial; the intervention (HMB/Arg/Gln) is a nutritional supplement mixture, not a drug; and the endpoints (mucositis incidence, body weight loss) are not time-to-event efficacy outcomes.待处理
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial.Lancet Digit HealthPMID 37775187PMC109218472023-Oct0.98未发现恶性肿瘤人群证据。待处理
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.Nat MedPMID 37783969PMC105790522023-Oct0.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study.Lancet HaematolPMID 37793771无 PMCID2023-Oct0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial.Lancet HaematolPMID 37793772无 PMCID2023-Oct0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies.Autism ResPMID 37794745无 PMCID2023-Oct0.98未发现恶性肿瘤人群证据。待处理
Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial.Nat MedPMID 37814062PMC105790952023-Oct0.98未发现恶性肿瘤人群证据。待处理
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial.J Immunother CancerPMID 37903590PMC106191232023-Oct0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Posterior cervical foraminotomy versus anterior cervical discectomy for Cervical Brachialgia: the FORVAD RCT.Health Technol AssessPMID 37929307PMC106417112023-Oct0.98未发现恶性肿瘤人群证据。待处理
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.Health Technol AssessPMID 37929672PMC106418602023-Oct0.98未发现恶性肿瘤人群证据。待处理
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.LancetPMID 37499670无 PMCID2023-Sep-300.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT).BMC CancerPMID 37777738PMC105441472023-Sep-300.45This is a Phase II randomized trial protocol for radiation therapy (no drug intervention) with toxicity as the primary endpoint, lacking a time-to-event efficacy analysis or original results.待处理
Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial.BMJPMID 37748804PMC105186992023-Sep-250.98未发现恶性肿瘤人群证据。待处理
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial.LancetPMID 37524096PMC106221112023-Sep-230.96主要研究目的为安全性/毒性或卫生经济学,未见合格 time-to-event 疗效终点。待处理
Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults.VaccinePMID 37652823无 PMCID2023-Sep-220.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study.Arthritis Res TherPMID 37723577PMC105062672023-Sep-180.95The study is a randomized Phase III trial of a drug intervention (upadacitinib) with original results, but it is not in oncology (it is in rheumatology/ankylosing spondylitis) and does not report a time-to-event efficacy endpoint.待处理
Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trial.Arthritis Res TherPMID 37715294PMC105031522023-Sep-150.98未发现恶性肿瘤人群证据。待处理
Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19.J Patient Rep OutcomesPMID 37702920PMC104997662023-Sep-130.98未发现恶性肿瘤人群证据。待处理
Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial.BMJ OpenPMID 37709311PMC111486982023-Sep-130.98未发现恶性肿瘤人群证据。待处理
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study.Blood AdvPMID 37276510PMC104719262023-Sep-120.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma.Blood AdvPMID 37379264PMC104719382023-Sep-120.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301.J Clin OncolPMID 37379502无 PMCID2023-Sep-100.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.LancetPMID 37591292无 PMCID2023-Sep-090.98未发现恶性肿瘤人群证据。待处理
Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.Sci RepPMID 37684299PMC104916262023-Sep-080.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer.Int J Gynecol CancerPMID 37666539无 PMCID2023-Sep-040.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.LancetPMID 37516125无 PMCID2023-Sep-020.98未发现恶性肿瘤人群证据。待处理
Dosimetric Evaluation of Organs at Risk From SAVE Protocol.Int J Radiat Oncol Biol PhysPMID 37023988无 PMCID2023-Sep-010.85This is a randomized Phase III trial in human oncology, but the intervention is brachytherapy (non-drug), and the primary outcome reported is dosimetric evaluation of organs at risk, not a time-to-event efficacy endpoint. The abstract mentions no isolated vaginal recurrences, but this is a safety/dosimetric report, not a primary efficacy analysis.待处理
Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial.Am J PsychiatryPMID 37132201无 PMCID2023-Sep-010.98未发现恶性肿瘤人群证据。待处理
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse.J Clin OncolPMID 37257143PMC108523662023-Sep-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin-Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial.J Am Soc NephrolPMID 37303085PMC104820622023-Sep-010.98未发现恶性肿瘤人群证据。待处理
Association Between Biliary Pathogens, Surgical Site Infection, and Pancreatic Fistula: Results of a Randomized Trial of Perioperative Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy.Ann SurgPMID 37314221PMC108381952023-Sep-010.98未发现恶性肿瘤人群证据。待处理